Avodah, Inc.™

• If an organization requires extensive independent validation from platforms such as G2, TrustRadius, or Gartner Peer Insights, AvodahMed’s limited discoverable presence may complicate procurement.
• If transparent self-serve pricing and low-friction procurement are primary requirements, AvodahMed’s sales-led pricing approach may be unsuitable.
• If the organization uses an EHR platform not highlighted among AvodahMed’s published integrations, expect potentially heavier integration work or non-integrated workflows.
• If the organization has low tolerance for workflow instability, the historical release-note issues related to "stuck workflows" and EHR write-back should prompt a strict pilot, service-level commitments, and rollback plans.

• Mobile and workflow step issues (users reporting states such as "stuck" or skipped steps)
• Send-to-EHR crash/failure incidents noted in release updates
• SSO login continuous loading reported in partner context (Veradigm SSO issue referenced)

Sources: App Store version history and AvodahMed release notes. (https://apps.apple.com/us/app/avodahmed/id6740938902, https://customers.avodahmed.com/knowledgehub/avodahmed-release-25)

• SOC 2 Type I vs Type II and report availability
• Subprocessor list and hosting providers
• Data retention policies for audio and transcripts
• Audit log detail and exportability
• Full EHR integration list beyond athenahealth and Veradigm
• Android Play Store listing: public materials reference iOS and Android support but a Google Play listing URL was not captured in this research pass; validate during procurement. (https://www.avodah.com/med/capabilities)

On AvodahMed’s product page, vendor-published testimonials include statements such as:

• "AvodahMed’s Ambient Scribe has enhanced my practice by improving documentation efficiency and quality of each examination…" — attributed to Allen L. Gee, MD, PhD, FAAN. (Vendor product overview and feature pages)
• "I’m seeing better efficiency and real-time savings." — attributed to Dr. Bonema, Troy Internal Medicine. (Vendor product overview and feature pages)

On avodahmed.com:

• "reducing my documentation time by nearly 70%…" — attributed to Katie Janiszwski, MSOP, CPO. (Vendor product overview and feature pages)

Caution: these are vendor-published testimonials and are anecdotal; they lack details on baseline measurements, sample sizes, and methodology.

Because product review data is sparse, employee reviews may provide indirect signals about operational maturity and support risk.

• An employee review site entry for "Avodah" shows a below-average rating with a modest review footprint and allegations including workplace culture concerns, turnover, and payroll issues. (Employee review site)

Note: there is a risk of name collisions (e.g., "Avodah" is also the name of a nonprofit), so employee-review data should be treated as an indicator of potential risk rather than conclusive product-quality evidence.

Publicly available formal case studies (with baseline metrics, sample sizes, and methodology) were limited. Available evidence includes:

• Veradigm pilot result: reported modest per-encounter time savings in partner/industry coverage. Critical details such as number of clinicians, specialties, measurement methodology, and persistence of savings are not documented in the public summary and require direct vendor/partner validation. (Industry press coverage)
• Vendor testimonials claiming large documentation time reductions; these claims lack independent verification and methodological detail. (Vendor product and testimonial pages)

Company sizes

• Likely suited for small-to-medium-sized practices and groups able to adopt new clinical workflows, and for organizations within the Veradigm customer base.
• Potentially suitable for mid-market healthcare organizations needing SSO and role-based access.

Industries/verticals

• Outpatient clinics, multi-specialty groups, organizations using Veradigm EHR or athenahealth.

Roles/personas

• Economic buyer: practice owner/administrator, CMIO, operations leader
• Technical buyer: IT/security lead (SSO, HIPAA, vendor risk)
• End users: physicians, advanced practice providers, scribes/clinical staff involved in note quality assurance

Pain points addressed

• clinician documentation burden and after-hours charting
• standardizing note structure across clinicians
• EHR workflow friction and manual documentation tasks

Deal disqualifiers

• organizations requiring extensive third-party reviews and benchmark reports before purchase
• organizations that require Epic-first native integration (unless AvodahMed can demonstrate support)
• very low-budget solo practices seeking transparent public pricing and strict low-cost limits

Avodah, Inc. provides a platform for language-related workflows with two primary divisions:

• AvodahMed: ambient clinical documentation and workflow automation for healthcare providers (real-time transcription, structured notes such as SOAP, and EHR workflows).
• AvodahConnect: governed translation and language workflows focused on scripture translation, language preservation, and sign-language/accessibility initiatives.

Avodah describes language as a "system of record" and emphasizes governance, accountability, and workflow controls as design priorities rather than positioning the offering as a standalone point tool. (Official vendor site and product overview pages)

AvodahMed

• Primary market: US healthcare providers (ambulatory practices, and via channel partnerships such as the Veradigm/Allscripts ecosystem).
• Positioning: reduce clinician documentation burden, maintain workflow continuity inside the EHR, and support clinician review and control of generated notes. (Vendor product and med-specific pages)

AvodahConnect

• Primary market: faith-based translation organizations, language preservation groups, and accessibility/sign-language initiatives.
• Positioning: governed, community-led translation workflows where human authority is explicit and AI is constrained to assist rather than decide. (Vendor connect product pages and knowledge hub)